NAPLES, FL – The Bruce and Cynthia Sherman Charitable Foundation announced its annual call for nominations for the 2020 Sherman Prizes, recognizing exceptionally talented, dedicated individuals working tirelessly to improve outcomes for people with Crohn’s disease and ulcerative colitis, and advancing research that could lead to prevention, remission, and cures.
Established in 2016, the Sherman Prize program is the first of its kind, providing financial prizes and national recognition to individuals who exemplify excellence in Crohn’s disease and ulcerative colitis, also known as the inflammatory bowel diseases (IBDs).
“My wife Cynthia and I created the Sherman Prize to celebrate excellence in IBD and inspire greater advances so fewer families have to face the challenges of these diseases,” said Bruce Sherman, Founder of the Sherman Prize. “It’s been inspiring to see the innovative work being done by brilliant IBD professionals. We’re excited to begin our fifth year and we can’t wait to see who is nominated.”
To date, twelve IBD professionals, representing diverse specialties, have been honored through the Prize program. They include physician scientists, a pediatric IBD specialist, a colorectal surgeon, a psychiatrist specializing in IBD and a physician assistant. To learn more about the many ways they are making life better for people with IBD, watch their tribute films at ShermanPrize.org.
Nominations for the 2020 Prizes may be submitted at ShermanPrize.org into the summer. A final deadline will be announced later in the spring. The Prizes will be presented December 10 at the Advances in IBD (AIBD) conference in Orlando, Florida.
About the Sherman Prize Program
The Sherman Prize program honors out-of-the-box thinkers from a variety of professional disciplines who represent “Excellence in Crohn’s and Colitis” in their chosen endeavors, having dedicated their careers to the fight to overcome IBD.
Two $100,000 Sherman Prizes are awarded annually to IBD clinicians, surgeons, researchers and/or academics, recognizing exceptional and pioneering contributions that transform the care of people with IBD. This Prize honors visionaries who are driven to solve IBD’s most difficult challenges and whose work inspires future innovators.
A $25,000 Sherman Emerging Leader Prize is awarded to an IBD clinician, surgeon, researcher, academic, physician assistant, nursing professional, or public health advocate who, while early in his or her career, has contributed to an advancement and shows great promise for significant future contributions.
Sherman Prize honorees are selected by the Sherman Prize Board of Directors, with guidance from the Sherman Prize Selection Committee, chaired by Dr. Dermot P.B. McGovern, the Joshua L. and Lisa Z. Greer Endowed Chair in Inflammatory Bowel Disease Genetics at CedarsSinai. Joining him on the Selection Committee are Dr. Lee Denson, Cincinnati Children’s Hospital Medical Center; Dr. Mark Gerich, University of Colorado Crohn’s and Colitis Center; Dr. Sunanda Kane, Mayo Clinic; and Dr. Amy Lightner, Cleveland Clinic.
Full eligibility guidelines and guidance on how to submit a nomination may be found at: ShermanPrize.org